发明名称 Anthranilic acid amides and pharmaceutical use thereof
摘要 <p>The invention relates to anthranilic acid amide derivatives of formula I &lt;Chemistry id="chema01" num="0001"&gt;&lt;Image id="ia01" he="44" wi="82" file="IMGA0001.TIF" imgContent="chem" imgFormat="TIFF" /&gt;&lt;/Chemistry&gt; wherein Ar is represented by the subformula I&lt;Sub&gt;a&lt;/Sub&gt;&lt;Chemistry id="chema02" num="0002"&gt;&lt;Image id="ia02" he="43" wi="63" file="IMGA0002.TIF" imgContent="chem" imgFormat="TIFF" /&gt;&lt;/Chemistry&gt; wherein R&lt;Sub&gt;a&lt;/Sub&gt; represents H or lower alkyl, and R&lt;Sub&gt;1&lt;/Sub&gt; represents H or perfluoro lower alkyl, R&lt;Sub&gt;2&lt;/Sub&gt; represents H, halogen, C&lt;Sub&gt;2&lt;/Sub&gt;-C&lt;Sub&gt;7&lt;/Sub&gt;alkyl, C&lt;Sub&gt;2&lt;/Sub&gt;-C&lt;Sub&gt;7&lt;/Sub&gt;alkenyl or lower alkynyl; or Ar is represented by the subformula I&lt;Sub&gt;b&lt;/Sub&gt;, and &lt;Chemistry id="chema03" num="0003"&gt;&lt;Image id="ia03" he="23" wi="43" file="IMGA0003.TIF" imgContent="chem" imgFormat="TIFF" /&gt;&lt;/Chemistry&gt; R&lt;Sub&gt;1&lt;/Sub&gt; represents perfluoro lower alkyl, and R&lt;Sub&gt;2&lt;/Sub&gt; represents bromo, iodo, C&lt;Sub&gt;2&lt;/Sub&gt;-C&lt;Sub&gt;7&lt;/Sub&gt;alkyl, C&lt;Sub&gt;2&lt;/Sub&gt;-C&lt;Sub&gt;7&lt;/Sub&gt;alkenyl or lower alkynyl, or R&lt;Sub&gt;1&lt;/Sub&gt; represents H, and R&lt;Sub&gt;2&lt;/Sub&gt; represents fluoro, bromo, indo, ethyl, C&lt;Sub&gt;5&lt;/Sub&gt;-C&lt;Sub&gt;7&lt;/Sub&gt;alkyl, C&lt;Sub&gt;2&lt;/Sub&gt;-C&lt;Sub&gt;7&lt;/Sub&gt;alkenyl or lower alkynyl; to N-oxides and tautomers thereof, and to salts of such anthranilic acid amides, its N-oxides and tautomers; to processes for their preparation; to their application in the treatment of the human or animal body, to the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment especially of a neoplastic disease, such as a tumor disease, of retinopathy or age-related macular degeneration; to a method for the treatment of such diseases in animals; and to the use of such a compound - alone or in combination with one or more other pharmaceutically active compounds - for the manufacture of a pharmaceutical preparation for the treatment of a neoplastic disease, of retinopathy or age-related macular degeneration.</p>
申请公布号 EP2269988(A3) 申请公布日期 2011.02.16
申请号 EP20100180423 申请日期 2002.11.07
申请人 NOVARTIS AG 发明人 BOLD, GUIDO;FURET, PASCAL;MANLEY, PAUL W.
分类号 C07D213/38;A61K31/165;A61K31/166;A61K31/44;A61K31/4409;A61P3/10;A61P9/10;A61P11/06;A61P15/00;A61P17/06;A61P19/02;A61P27/00;A61P27/06;A61P29/00;A61P35/00;A61P35/02;C07C231/12;C07C237/40;C07D213/89 主分类号 C07D213/38
代理机构 代理人
主权项
地址